Skip to main content

Applications for Transgenic Animals in Toxicology

  • Conference paper

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 17))

Abstract

The development of transgenic animals has already had a significant impact in biomedical research. Non-human models of human diseases (i.e., sickle cell disease, cystic fibrosis and AIDS) have been produced in mice and are being used to screen potential therapies (Breslow, 1994). Domesticated animals genetically engineered to: (a) resist disease, (b) produce meat or eggs with less cholesterol, or (c) accelerate growth may be introduced into agriculture in the near future (Sedlak, 1989). Transgenic animals have also been proposed as living bioreactors for the commercial production of pharmaceuticals and other biologicals not easily synthesized by other methods (Van Brunt, 1988).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Breslow J (1994) Lipoproteins and heart disease. Bio/Technology 12:365–370

    Article  PubMed  CAS  Google Scholar 

  • Camper SA (1987) Research applications of transgenic mice. Bio Techniques 5: 638–650

    Google Scholar 

  • Genetic Engineering News, University Gen Beat, June 1, 1994

    Google Scholar 

  • Gordon J, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle F (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. 77:7380–7384

    Article  PubMed  CAS  Google Scholar 

  • Gossen J, Vijg J (1993) Transgenic mice as model systems for studying gene mutations in vivo. TIG 9:27–31

    Article  PubMed  CAS  Google Scholar 

  • Jaenisch R (1976) Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc. Natl. Acad. Sci. 73:1260–1264

    Article  PubMed  CAS  Google Scholar 

  • Kuehn MR, Bradley A, Robertson EJ, Evans MJ (1987) A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326:295–298

    Article  PubMed  CAS  Google Scholar 

  • Mark WH (1992) Manipulation of the mouse genome using embryonic stem cells. Lab Animal 21:41–53

    Google Scholar 

  • Matsukuma S, Nakatsuru Y, Nakagawa K, Utakoji T, Sugano H, Kataoka H, Sekiguchi M, Ishikawa T (1989) Enhanced 06 -methylguanine-DNA methyltransferase activity in transgenic mice containing an integrated E. coli ada repair gene. Mutation Research 218:197–206

    PubMed  CAS  Google Scholar 

  • Raines LH (1988) The mouse that roared. Issues in Science and Technology 4:64–70

    Google Scholar 

  • Saffer JD (1992) Transgenic mice in biomedical research. Lab Animal 21:30–38

    Google Scholar 

  • Sanders B (1994) Stress proteins as molecular chaperons: implications for toxicology. Environmental Health Perspective 102:538–540

    Article  CAS  Google Scholar 

  • Sedlak BJ (1989) Transgenics enters commercial arena with high hopes for the 1990s. The Medical Business Journal 5:61,67–70

    Google Scholar 

  • Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendesohn M, Charron J, Datta M, Young F, Stall AM, Alt FW (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 6:68

    Google Scholar 

  • Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee S (1994) Limb alterations inbrachypodism mice due to mutations in a new member of the TGF-B- superfamily. Nature 368:639–642

    Article  PubMed  CAS  Google Scholar 

  • Sullivan N, Gatehouse D, Tweats D (1993) Mutation, cancer and transgenic models: relevance to the toxicology industry. Mutagenesis 8:167–174

    Article  PubMed  CAS  Google Scholar 

  • Van Brunt J (1990) Transgenics primed for research. Bio/Technology 8:725–728

    Article  PubMed  Google Scholar 

  • Van Brunt J (1988) Molecular fanning: transgenic animals as bioreactors. Bio/Technology 6:1149–1154

    Article  Google Scholar 

  • Whiting S, Marshall H, Coole M, Krumlanf R, Rigby PWJ, Stott D, Allenmann RK (1991) Multiple spatially specific enhancers are required to reconstruct the pattern of Hox-2.6 gene expression. Genes Dev. 5:2048–2059

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Brusick, D. (1995). Applications for Transgenic Animals in Toxicology. In: Degen, G.H., Seiler, J.P., Bentley, P. (eds) Toxicology in Transition. Archives of Toxicology, vol 17. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79451-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79451-3_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79453-7

  • Online ISBN: 978-3-642-79451-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics